Intelligent Bio Solutions Inc.
INBS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $9 | $9 | $8 | $6 |
| - Cash | $2 | $1 | $3 | $2 |
| + Debt | $2 | $0 | $1 | $1 |
| Enterprise Value | $9 | $8 | $6 | $5 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 31.7% | 15.8% | 20% | – |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 46.6% | 39.8% | 46.8% | 36.7% |
| EBITDA | -$3 | -$3 | -$2 | -$2 |
| % Margin | -240.7% | -330.9% | -306.5% | -318.6% |
| Net Income | -$3 | -$3 | -$3 | -$2 |
| % Margin | -268.3% | -366.1% | -349% | -370.3% |
| EPS Diluted | -3.5 | -4.4 | -4.4 | -5 |
| % Growth | 20.5% | 0% | 12% | – |
| Operating Cash Flow | -$3 | -$2 | -$3 | -$2 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$3 | -$2 | -$3 | -$2 |